Pfizer Inc (PFE)
31 Jul 2015
- U.S. stocks ended sharply higher on Tuesday, breaking a five-day losing streak as attention shifted from trouble in Chinese equities to U.S. corporate earnings and to speculation the first Federal Reserve interest rate hike may not come until December.
- Pfizer Inc on Tuesday reported better-than-expected second-quarter profit and revenue, helped by strong demand for its pneumonia vaccine and new breast cancer drug, sending its shares up 1 percent.
July 28 - Pfizer Inc on Tuesday reported better-than-expected second-quarter profit and revenue, helped by strong demand for its pneumonia vaccine and new breast cancer drug, sending its shares up 1 percent.
* Futures up: Dow 71 pts, S&P 10 pts, Nasdaq 18 pts (Adds details, comment, updates prices)
July 28 - U.S. drugmaker Pfizer Inc reported a 7 percent fall in quarterly revenue, hurt by a strong dollar.
- Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee.
July 27 - Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee.
BRUSSELS, July 24 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
July 15 - Pfizer Ltd : * Intimated the concerned authorities that it intends to effect closure of its plant situated at thane belapur road, navi Mumbai * Decision To close the plant is based on an assessment of its long term viability and its ability to achieve the needed production * Closure will not impact the supply of any of the company's medicines to patients * There has practically been no production activity at this plant since 2013 * Source text: http://bit.ly/1f2pgRU * F
MUMBAI - The U.S. Food and Drug Administration has banned drug imports from an India manufacturing unit of Emcure Pharmaceuticals Ltd over violations of standard manufacturing practices, the latest in a series of Indian firms to face such action.
|Johnson & Johnson (JNJ.N)||$100.21||+0.37|
|Novartis AG (NOVN.VX)||CHF101.00||+0.60|
|Merck & Co., Inc. (MRK.N)||$58.96||+0.44|
|Roche Holding Ltd. (ROG.VX)||CHF280.80||+1.70|
|Abbott Laboratories (ABT.N)||$50.69||-0.08|
|Bayer AG (BAYGn.DE)||€133.95||-0.35|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€98.54||+0.57|
|AstraZeneca plc (AZN.L)||4,321.50p||+1.50|
|GlaxoSmithKline plc (GSK.L)||1,398.00p||+2.00|
Earnings vs. Estimates
Analyst Research Reports
Provider : ValuEngine, Inc.
Provider : Wright Reports
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : S&P Capital IQ – STARS Reports
Provider : Stock Traders Daily
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.